| 1 |
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| 2 |
Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: Global trends, etiology and risk factors[J]. World J Oncol, 2019, 10(1): 10-27.
|
| 3 |
冯程程, 许传志, 何杰宇,等.1990-2019年中国20 ~ 84岁人群胰腺癌发病趋势分析[J].中华肿瘤防治杂志, 2022, 29(18):1323-1329.
|
| 4 |
Ariston Gabriel AN, Wang F, Jiao Q, et al. The involvement of exosomes in the diagnosis and treatment of pancreatic cancer [J]. Mol Cancer, 2020, 19(1): 132.
|
| 5 |
Yang J, Xu R, Wang C, et al. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review[J]. Cancer Commun (Lond), 2021, 41(12):1257-1274.
|
| 6 |
Hoshino A, Kim HS, Bojmar L, et al. Extracellular vesicle and particle biomarkers define multiple human cancers[J]. Cell, 2020, 182(4): 1044-1061. e18.
|
| 7 |
Lau C, Kim Y, Chia D, et al. Role of pancreatic cancer-derived exosomes in salivary biomarker development [J]. J Biol Chem, 2013, 288(37): 26888-26897.
|
| 8 |
Liu J, Ren L, Li S, et al. The biology, function, and applications of exosomes in cancer[J]. Acta Pharm Sin B, 2021, 11(9): 2783-2797.
|
| 9 |
McKiernan J, Donovan M J, O'Neill V, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy [J]. J AMA Oncology, 2016, 2(7).
|
| 10 |
Jiao YJ, Jin DD, Jiang F, et al. Characterization and proteomic profiling of pancreatic cancer-derived serum exosomes [J]. J Cell Biochem, 2019, 120(1): 988-999.
|
| 11 |
Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer [J]. Eur J Surg Oncol, 2007, 33(3): 266-270.
|
| 12 |
Jin H, Liu P, Wu Y, et al. Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer [J]. Cancer Sci, 2018, 109(9): 2946-2956.
|
| 13 |
Yang J, Zhang Y, Gao X, et al. Plasma-derived exosomal ALIX as a novel biomarker for diagnosis and classification of pancreatic cancer[J]. Front Oncol, 2021, 11: 628346.
|
| 14 |
Madhavan B, Yue S, Galli U, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity[J]. Int J Cancer, 2015, 136(11):2616-2627.
|
| 15 |
Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment[J]. Gut, 2022, 71(3):568-579.
|
| 16 |
Costa-Silva B, Aiello NM, Ocean AJ, et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver[J]. Nat Cell Biol, 2015, 17(6):816-826.
|
| 17 |
Matsushita H, Yang YM, Pandol SJ, et al. Exosome migration inhibitory factor as a marker and therapeutic target for pancreatic cancer[J]. Gastroenterology, 2016, 150(4):1033-1035.
|
| 18 |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci U S A, 2008, 105(30):10513-10518.
|
| 19 |
Wang X, Luo G, Zhang K, et al. Hypoxic Tumor-derived exosomal miR-301a Mediates M2 macrophage polarization via PTEN/PI3Kgamma to promote pancreatic cancer metastasis [J]. Cancer Res, 2018, 78(16):4586-4598.
|
| 20 |
Shang D, Xie C, Hu J, et al. Pancreatic cancer cell-derived exosomal microRNA-27a promotes angiogenesis of human microvascular endothelial cells in pancreatic cancer via BTG2[J]. J Cell Mol Med, 2020, 24(1):588-604.
|
| 21 |
Goto T, Fujiya M, Konishi H, et al. An elevated expression of serum exosomal microRNA-191, -21, -451a of pancreatic neoplasm is considered to be efficient diagnostic marker [J]. BMC Cancer, 2018, 18(1):116.
|
| 22 |
Lai X, Wang M, McElyea SD, et al. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer[J]. Cancer Lett, 2017, 393:86-93.
|
| 23 |
Wang L, Wu J, Ye N, et al. Plasma-derived exosome MiR-19b acts as a diagnostic marker for pancreatic cancer[J]. Front Oncol, 2021, 11: 739111.
|
| 24 |
Zhang WT, Zhang JJ, Shao Q, et al. FGD5AS1 is an oncogenic lncRNA in pancreatic cancer and regulates the Wnt/betacatenin signaling pathway via miR577[J]. Oncol Rep, 2022, 47(1):1-11.
|
| 25 |
Takahashi K, Ota Y, Kogure T, et al. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer[J]. Cancer Sci, 2020, 111(1):98-111.
|
| 26 |
Robless EE, Howard JA, Casari I, et al. Exosomal long non-coding RNAs in the diagnosis and oncogenesis of pancreatic cancer[J]. Cancer Lett, 2021, 501:55-65.
|
| 27 |
Xu H, Zhou J, Tang J, et al. Identification of serum exosomal lncRNA MIAT as a novel diagnostic and prognostic biomarker for gastric cancer [J]. J Clin Lab Anal, 2020, 34(8):e23323.
|
| 28 |
Liang ZX, Liu HS, Wang FW, et al. LncRNA RPPH1 promotes colorectal cancer metastasis by interacting with TUBB3 and by promoting exosomes-mediated macrophage M2 polarization[J]. Cell Death Dis, 2019, 10(11):829.
|
| 29 |
Yu S, Li Y, Liao Z, et al. Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma[J]. Gut, 2020, 69(3):540-550.
|
| 30 |
Zong T, Yang Y, Zhao H, et al. tsRNAs: Novel small molecules from cell function and regulatory mechanism to therapeutic targets[J]. Cell Prolif, 2021, 54(3):e12977.
|
| 31 |
Zhu L, Li J, Gong Y, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis[J]. Mol Cancer, 2019, 18(1): 74.
|
| 32 |
Chen H, Xu Z, Cai H, et al. Identifying differentially expressed tRNA-derived small fragments as a biomarker for the progression and metastasis of colorectal cancer[J]. Dis Markers, 2022, 2022:2646173.
|
| 33 |
Wang J, Ma G, Ge H, et al. Circulating tRNA-derived small RNAs (tsRNAs) signature for the diagnosis and prognosis of breast cancer[J]. NPJ Breast Cancer, 2021, 7(1):4.
|
| 34 |
Jin F, Yang L, Wang W, et al. A novel class of tsRNA signatures as biomarkers for diagnosis and prognosis of pancreatic cancer[J]. Mol Cancer, 2021, 20(1): 95.
|
| 35 |
Xue M, Shi M, Xie J, et al. Serum tRNA-derived small RNAs as potential novel diagnostic biomarkers for pancreatic ductal adenocarcinoma[J]. Am J Cancer Res, 2021, 11(3):837-848.
|
| 36 |
Yu W, Hurley J, Roberts D, et al. Exosome-based liquid biopsies in cancer: opportunities and challenges[J]. Ann Oncol, 2021, 32(4):466-477.
|
| 37 |
Allenson K, Castillo J, San Lucas FA, et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients[J]. Ann Oncol, 2017, 28(4):741-747.
|
| 38 |
Bernard V, Kim DU, San Lucas FA, et al. Circulating nucleic acids are associated with outcomes of patients with pancreatic cancer[J]. Gastroenterology, 2019, 156(1):108-118. e4.
|
| 39 |
Campos-Carrillo A, Weitzel JN, Sahoo P, et al. Circulating tumor DNA as an early cancer detection tool[J]. Pharmacol Ther, 2020, 207: 107458.
|
| 40 |
Tao L, Zhou J, Yuan C, et al. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer[J]. Metabolomics, 2019, 15(6):86.
|
| 41 |
Sharma B, Kanwar SS. Phosphatidylserine: A cancer cell targeting biomarker [J]. Semin Cancer Biol, 2018, 52(Pt 1):17-25.
|
| 42 |
Sharma R, Huang X, Brekken R A, et al. Detection of phosphatidylserine-positive exosomes for the diagnosis of early-stage malignancies[J]. Br J Cancer, 2017, 117(4):545-552.
|
| 43 |
Gao F, Jiao F, Xia C, et al. A novel strategy for facile serum exosome isolation based on specific interactions between phospholipid bilayers and TiO2[J]. Chem Sci, 2019, 10(6):1579-1588.
|
| 44 |
Kimura H, Yamamoto H, Harada T, et al. CKAP4, a DKK1 receptor, is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy[J]. Clin Cancer Res, 2019, 25(6):1936-1947.
|
| 45 |
魏倩, 李泽, 冯红蕾. 胰腺癌患者血清外泌体酪氨酸蛋白激酶受体EphA2蛋白表达变化及其意义[J]. 山东医药, 2021, 61(9):31-34.
|
| 46 |
Odaka H, Hiemori K, Shimoda A, et al. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma[J]. BMC Gastroenterol, 2022, 22(1):153.
|
| 47 |
Sakaue T, Koga H, Iwamoto H, et al. Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer[J]. Med Mol Morphol, 2019, 52(4):198-208.
|
| 48 |
Chen K, Wang Q, Liu X, et al. Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression [J]. Int J Biol Sci, 2022, 18(3):1220-1237.
|
| 49 |
Wang C, Wang J, Cui W, et al. Serum exosomal miRNA-1226 as potential biomarker of pancreatic ductal adenocarcinoma[J]. Onco Targets Ther, 2021, 14: 1441-1451.
|
| 50 |
Kawamura S, Iinuma H, Wada K, et al. Exosome-encapsulated microRNA-4525, microRNA-451a and microRNA-21 in portal vein blood is a high-sensitive liquid biomarker for the selection of high-risk pancreatic ductal adenocarcinoma patients[J]. J Hepatobiliary Pancreat Sci, 2019, 26(2):63-72.
|
| 51 |
Guo Z, Wang X, Yang Y, et al. Hypoxic tumor-derived exosomal long noncoding RNA UCA1 promotes angiogenesis via miR-96-5p/AMOTL2 in pancreatic cancer [J]. Mol Ther Nucleic Acids, 2020, 22: 179-195.
|
| 52 |
任潇凡, 李志花. 外泌体lncRNA CCAT1在胰腺癌中的表达及其临床意义 [J]. 岭南现代临床外科, 2019, 19(1):23-27.
|
| 53 |
Sun Z, Sun D, Feng Y, et al. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer[J]. Mol Ther Nucleic Acids, 2021, 26:253-268.
|
| 54 |
Liu Y, Tang T, Yang X, et al. Tumor-derived exosomal long noncoding RNA LINC01133, regulated by periostin, contributes to pancreatic ductal adenocarcinoma epithelial-mesenchymal transition through the Wnt/beta-catenin pathway by silencing AXIN2[J]. Oncogene, 2021, 40(17):3164-3179.
|
| 55 |
Feng Z, Li K, Qin K, et al. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA[J]. J Hematol Oncol, 2022, 15(1):1-22.
|
| 56 |
Ohshima K, Hatakeyama K, Kanto K, et al. Comparative proteomic analysis identifies exosomal Eps8 protein as a potential metastatic biomarker for pancreatic cancer [J]. Oncol Rep, 2019, 41(2):1019-1034.
|
| 57 |
Osteikoetxea X, Benke M, Rodriguez M, et al. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice[J]. Biochem Biophys Res Commun, 2018, 499(1):37-43.
|
| 58 |
Zheng J, Hernandez J M, Doussot A, et al. Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer [J]. Hpb, 2018, 20(7):597-604.
|
| 59 |
Yee N S, Zhang S, He H Z, et al. Extracellular vesicles as potential biomarkers for early detection and diagnosis of pancreatic cancer[J]. Biomedicines, 2020, 8(12):581.
|